We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+15.91%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$177M
AUM Growth
-$15.4M
Cap. Flow
-$42.5M
Cap. Flow %
-23.96%
Top 10 Hldgs %
53.79%
Holding
76
New
22
Increased
8
Reduced
9
Closed
31

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.61M
2
GSK icon
GSK
GSK
+$5.7M
3
LLY icon
Eli Lilly
LLY
+$4.59M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$4.49M
5
BSX icon
Boston Scientific
BSX
+$4.13M

Top Sells

Rank Stock Value
1
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$10.1M
2
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$7.7M
3
BIIB icon
Biogen
BIIB
+$4.87M
4
QTNT
Quotient Limited Ordinary Shares
QTNT
+$4.41M
5
GMED icon
Globus Medical
GMED
+$4.38M

Sector Composition

Rank Sector Weight
1 Healthcare 49.3%
2 Financials 5.91%
3 Technology 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNS icon
51
Avanos Medical
AVNS
– –
-86,914
Closed -$3.91M
BIIB icon
52
Biogen
BIIB
$30.4B
– –
-15,549
Closed -$4.87M
DBVT
53
PUT
DBV Technologies
DBVT
$799M
– –
-1,820
Closed -$772K
EVH icon
54
Evolent Health
EVH
$421M
– –
-78,600
Closed -$1.4M
GMED icon
55
Globus Medical
GMED
$10.9B
– –
-147,364
Closed -$4.38M
GSK icon
56
CALL
GSK
GSK
$108B
– –
-80,000
Closed -$4.06M
INSM icon
57
PUT
Insmed
INSM
$22.6B
– –
-266,800
Closed -$8.33M
ITGR icon
58
Integer Holdings
ITGR
$3.41B
– –
-51,258
Closed -$2.62M
MDGL icon
59
Madrigal Pharmaceuticals
MDGL
$12.4B
– –
-26,958
Closed -$1.21M
MDT icon
60
Medtronic
MDT
$111B
– –
-55,844
Closed -$4.34M
SNY icon
61
Sanofi
SNY
$109B
– –
-45,099
Closed -$2.25M
SYRE icon
62
Spyre Therapeutics
SYRE
$8.68B
– –
-5,183
Closed -$639K
ZBH icon
63
Zimmer Biomet
ZBH
$18.5B
– –
-31,964
Closed -$3.63M
ZTS icon
64
PUT
Zoetis
ZTS
$32.5B
– –
-50,000
Closed -$3.19M
VIRX
65
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-963
Closed -$65K
EGRX
66
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-63,835
Closed -$3.81M
CBAY
67
DELISTED
Cymabay Therapeutics
CBAY
– –
-75,000
Closed -$605K
DMK
68
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-27,657
Closed -$10.1M
SGEN
69
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-100,000
Closed -$5.44M
SIOX
70
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-139,862
Closed -$7.7M
SIOX
71
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-454,838
Closed -$25M
OTIC
72
DELISTED
Otonomy, Inc.
OTIC
– –
-100,900
Closed -$328K
OTIC
73
PUT
DELISTED
Otonomy, Inc.
OTIC
– –
-100,900
Closed -$328K
ARNA
74
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-72,086
Closed -$1.84M
LMNX
75
DELISTED
Luminex Corp
LMNX
– –
-115,979
Closed -$2.36M
1 2
3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Sio Capital Management held 76 positions worth $177M, down 8% from $193M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sio Capital Management withdrew a net $42.5M in Q4 2017, closing 31 positions and reducing 9 holdings. Its most notable exit was DMK Pharmaceuticals Corporation Common Stock, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Financials and Technology.

Against the trend, Sio Capital Management opened a new position in Eli Lilly worth $4.55M.

  • Sio Capital Management's largest Q4 2017 buy was Eli Lilly: 53,900 shares worth $4.55M.
  • Sio Capital Management added most to Elevance Health in Q4 2017, an estimated $6.61M increase.
  • Sio Capital Management's biggest Q4 2017 reduction was Quotient Limited Ordinary Shares, cutting an estimated $4.41M.
  • Sio Capital Management fully exited DMK Pharmaceuticals Corporation Common Stock in Q4 2017, selling an estimated $10.1M.
  • Sio Capital Management's ten largest holdings make up 54% of its $177M portfolio in Q4 2017.
  • Sio Capital Management opened 22 new positions and closed 31 in Q4 2017.
  • Sio Capital Management's portfolio value fell 8% quarter-over-quarter to $177M.

Based on Sio Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.